Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy: Molecular Therapy - Oncolytics

Cells, Free Full-Text

Molecular and therapeutic effect of CRISPR in treating cancer

Frontiers Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells - Xie - 2021 - Advanced Science - Wiley Online Library

PD-1 gene editing by sgRNA/Cas9 RNP assembly in primary human T cells.

Genome Editing in Engineered T Cells for Cancer Immunotherapy

Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte -based adoptive T cell therapy: Molecular Therapy - Oncolytics

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy, Molecular Cancer

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy, Cancer Cell International